Alterity Therapeutics Ltd. (ATHE) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Hozirgi uzoq muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics (ATHE) moliyaviy holatini namoyish etadi, uning kengayish imkoniyatlari esa anti-parkinsonizm formulasining tasdiqlanishiga bog'liq. 0.00 ko'rsatkichi qarz olish darajasini belgilaydi, shu bilan birga AQSh va Avstraliyadagi ilmiy jamoa innovatsion poydevor yaratmoqda. Rivojlanish tashqi M&A kelishuvlariga kirishmasdan, terapevtik platformani tasdiqlash uchun shifoxonalar bilan klinik ittifoqlarga tayanadi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_ATHE_-_Alterity-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "ATHE - Alterity Therapeutics Ltd Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Alterity Therapeutics Ltd. (ATHE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Alterity Therapeutics|ATHE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Alterity Therapeutics Ltd|ATHE - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Alterity Therapeutics Limited|ATHE - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Alterity Therapeutics|Shoshilinch likvidlik alteritytherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:alteritytherapeutics.com
Uzoq muddatli kredit yuki baholashi kompaniyaning tashqi moliyaviy zarbalarga chidamliligini belgilaydi. Ushbu ko'rsatkich bir yildan ortiq muddatga ega majburiyatlarning umumiy kapitalga nisbati sifatida hisoblanadi. Uzoq muddatli qarzning kapitalga nisbati dinamikasini tahlil qilish orqali investor majburiyatlar tuzilmasidagi o'zgarishlarni kuzatadi. Alterity Therapeutics (ATHE) uchun past qarz yukining mavjudligi kritik ahamiyatga ega, chunki bu klinik sinovlar yakunlanguniga va dori vositalarining haqiqiy tijoratlashtirilguniga qadar biznesning barqarorligini ta'minlaydi.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati AMLX (Amylyx Pharmaceuticals Inc)|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati PRAX (Praxis Corp)|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Omeros Corp. (OMER) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati ACIU|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX: Uzoq muddatli kreditlarning kapitalga nisbati|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|Uzoq muddatli qarzning kapitalga koeffitsiyenti OVID|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|CRVO - Uzoq muddatli qarzning kapitalga nisbati|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PEPG (PepGen)|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati relmada.com RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|Uzoq muddatli qarzning kapitalga nisbati gracetx.com (GRCE)|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati KLTO (ANEW Medical)|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp (PASG) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning kapitalga nisbati minervaneurosciences.com (NERV)|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ADXN (Addex Therapeutics Ltd.)|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CYCN (Cyclerion Therapeutics)|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati sagerx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzning o'z kapitaliga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati WENA (Anew Medical Inc.)|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati